Innodem raises $6m in Morningside-led Series A round

Montreal-based Innodem Neurosciences has secured US$6 million in a Series A financing led by Morningside Ventures.

19 January 2021•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.